Compared to patients with papRCC, patients with ccRCC exhibited a significantly higher level of CD8+ T cells (Figure 1E), which suggests that the protective role CD8+ T cells could be specific to patients with ccRCC. Here, CD8A is linked to nonpapillary renal cell carcinoma.